🇺🇸 FDA

Company profile · Sponsor

Generate

Generate Biomedicines

GENB · NYSE pharma SOMERVILLE, MA, USA
Pipeline
8
Drugs
0
Patents
1

Quick answer

Generate (GENB) is a pharma company. headquartered in SOMERVILLE, MA, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 1 patent to this profile..

Company facts

Ticker GENB
Exchange NYSE
Company type pharma
Headquarters SOMERVILLE, MA, USA
SEC CIK 0002100782

Pipeline (8)

Search pipeline →

  1. 0.9% sodium chloride, GB-0895

    Generate

    severe uncontrolled asthma

    phase 3 small molecule active

    1 trial

  2. GB-0895

    Generate

    Severe Asthma

    phase 3 small molecule active

    2 trials

  3. A Phase 1 Study to Investigate the Safety and Tolerability of the Study Drug GB-0895 in Mild to Moderate Asthma Patients or Single Dose in Chronic Obstructive Pulmonary Disease (COPD)

    Generate

    mild to moderate asthma, Chronic Obstructive Pulmonary Disease (COPD)

    phase 1 other active

    1 trial

  4. GB-0669

    Generate

    SARS CoV-2

    phase 1 small molecule completed

    1 trial

  5. GB-0895 (SC)

    Generate

    Asthma

    phase 1 mab active

    1 trial

  6. GB-4362

    Generate

    Advanced Urothelial Cancer

    phase 1 small molecule active

    1 trial

  7. GB-5267 - IV only

    Generate

    Platinum-resistant Ovarian Cancer

    phase 1 mab active

    1 trial

  8. GB-7624

    Generate

    Atopic Dermatitis (AD)

    phase 1 small molecule active

    1 trial

Patents (1)

Search patents →

  1. US 11993644

    Antigen binding molecules targeting SARS-CoV-2

    Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Generate?

Generate (GENB) is a pharma company. headquartered in SOMERVILLE, MA, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 1 patent to this profile..

What pipeline programs does Generate sponsor?

We track 8 ClinicalTrials.gov-linked programs for Generate, including 0.9% sodium chloride, GB-0895 and 7 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Generate company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.